These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Features of formation of antiviral resistance upon local application of the interferon inducer ridostin]. Masycheva VI; Danilenko ED; Ignat'ev GM; Fadina VA; Levagina GM Vopr Virusol; 1997; 42(3):126-8. PubMed ID: 9297343 [TBL] [Abstract][Full Text] [Related]
23. [Soviet-made interferon in the treatment of recurrent herpes simplex]. Khamaganova AV; Zhukova IK; Shekrota AG Vestn Dermatol Venerol; 1980 Apr; (4):53-5. PubMed ID: 6156553 [No Abstract] [Full Text] [Related]
24. Efficacy of 5,6-dihydro-5-azathymidine against cutaneous herpes simplex virus in hairless mice. Underwood GE; Weed SD Antimicrob Agents Chemother; 1977 Apr; 11(4):765-7. PubMed ID: 856033 [TBL] [Abstract][Full Text] [Related]
25. TLR3: interferon induction by double-stranded RNA including poly(I:C). Matsumoto M; Seya T Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679 [TBL] [Abstract][Full Text] [Related]
26. Results of a five-year study of the curative effect of double stranded ribonucleic acid in viral dermatoses and eye diseases. Borecky L; Buchvald J; Adlerova E; Stodola I; Obrucnikova E; Gruntova Z; Lackovic V; Doskocil J Adv Exp Med Biol; 1978; 110():175-91. PubMed ID: 215011 [TBL] [Abstract][Full Text] [Related]
27. [The antiviral drug bonafton in the treatment of viral skin diseases]. Pershin GN; Arievich AM; Bogdanova NS; Dolinskiĭ IuI; Kapankina LP Vestn Dermatol Venerol; 1983 Dec; (12):50-3. PubMed ID: 6369825 [No Abstract] [Full Text] [Related]
33. [Clinical comparison of two topical antiviral ointments in herpes]. Makleit L; Nagy M Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687 [TBL] [Abstract][Full Text] [Related]
34. Characterization of virus/double-stranded RNA-dependent induction of antimicrobial peptide hepcidin in trout macrophages. Chiou PP; Lin CM; Bols NC; Chen TT Dev Comp Immunol; 2007; 31(12):1297-309. PubMed ID: 17498800 [TBL] [Abstract][Full Text] [Related]
35. Development of gene-specific double-stranded RNA drugs. Barik S Ann Med; 2004; 36(7):540-51. PubMed ID: 15513304 [TBL] [Abstract][Full Text] [Related]
36. Impervious. Haggerty PF; Halsey ES Am J Med; 2009 Mar; 122(3):239-41. PubMed ID: 19272483 [No Abstract] [Full Text] [Related]
37. Role of complement inhibition in topical therapy of muco-cutaneous herpes simplex virus infections. Gancevici GG Roum Arch Microbiol Immunol; 1993; 52(4):293-303. PubMed ID: 7827366 [TBL] [Abstract][Full Text] [Related]
38. [New cortisone-vaccine cream for topical treatment of skin infections in the aged]. Canepa R Minerva Med; 1971 Nov; 62(84):4129-37. PubMed ID: 5136615 [No Abstract] [Full Text] [Related]
39. Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Traynor TR; Majde JA; Bohnet SG; Krueger JM Life Sci; 2004 Apr; 74(20):2563-76. PubMed ID: 15010266 [TBL] [Abstract][Full Text] [Related]
40. [Interferon therapy for herpes simplex virus infection in a 70 years old patient]. López García F; Enríquez Ascarza R; Rodríguez Martínez JC; Sirvent Pedreño AE An Med Interna; 2002 Nov; 19(11):600-1. PubMed ID: 12522901 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]